Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
News Medical on MSN
Novel laser focal therapy device shows promising results for prostate cancer treatment
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, and HALO ...
MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...
High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...
Lake Street Life-Sciences Invitational: Profound is scheduled to participate in a series of one-on-one meetings February 4 th- 5 th in Scottsdale, AZ. BTIG 13th Annual MedTech, Digital Health, Life ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
The MarketWatch News Department was not involved in the creation of this content. MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results